Boehringer Ingelheim, United States
Pfizer, Inc. (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)
OP-1C - Comparative Safety of Conjugated Estrogens/bazedoxifene (CE/BZA) versus Estrogen/progestin Combination Hormone Therapy (EP): A Multi-database Cohort Study
Wednesday, August 25, 20214:30 PM – 6:00 PM US Eastern Time